The Senate estimated that 25,301 years of work were lost in 2019 while federal employees were furloughed for more than a month, which may have limited their spending during the shutdown period, ...

The submission is based on results from the TEMPO clinical development program that evaluated the efficacy, safety and tolerability of tavapadon across a broad Parkinson's disease ...

Costs, Coverage and Trends.

NEW YORK, Sept. 9, 2025 /PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory ...

Immunic, Inc., a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, announced that it has received ...

From improv gigs to becoming one of the most famous faces in commercial history, Stephanie Courtney is more than just memorable Progressive ads.

The political theorist Corey Robin walks through the history of the Red Scare and the “fractured mirror” it is to Trump’s ...

Prog rock wasn’t content with three-minute love songs—it wanted twenty-minute epics about space travel, philosophy, or, you ...

With only one FDA-approved drug available for PPMS, this type of multiple sclerosis remains difficult to treat, but adaptive devices and wellness programs can help you manage your symptoms. For many ...

Sanofi has bolstered the case for its oral BTK inhibitor tolebrutinib as a treatment for multiple sclerosis (MS), due to be filed for approval in the latter half of this year, with new data in a ...

Sanofi has said it plans to start discussions about filing its oral BTK inhibitor tolebrutinib for multiple sclerosis, even though the drug only achieved its primary objective in one of three phase 3 ...

Being diagnosed with any incurable disease is distressing, but there are ways to improve your quality of life when living with PPMS. Typically, people with PPMS do not have distinct periods of relapse ...